Raedersdorf, France

Daniel Rueher

USPTO Granted Patents = 34 

 

 

Average Co-Inventor Count = 7.5

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • Basel, CH (2021)
  • Raedersdorf, FR (2013 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
34 patents (USPTO):

Title: The Innovations of Daniel Rueher: Revolutionizing Cancer Treatments

Introduction

Daniel Rueher, a prolific inventor hailing from Raedersdorf, FR, has made significant contributions to the field of pharmaceuticals with a total of 27 patents to his name. His groundbreaking research has focused on developing compounds for the treatment of various cancers, particularly targeting specific mutations in the epidermal growth factor receptor (EGFR).

Latest Patents

1. 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds: Rueher's invention provides compounds that act as selective allosteric inhibitors of T790M and C797S-containing EGFR mutants. These compounds are essential for the development of pharmaceutical compositions and serve as therapeutically active substances.

2. Isoindolinone and indazole compounds for the degradation of EGFR: Rueher's innovative compounds degrade EGFR, including mutant forms, by promoting ubiquitination of the protein and subsequent proteasomal degradation. These compounds show promise for the treatment of various types of cancer.

Career Highlights

Rueher has made significant strides in his career, having worked with renowned companies such as Hoffmann-La Roche Inc. (Roche) and C4 Therapeutics, Inc. at the forefront of pharmaceutical research and development. His expertise and dedication have paved the way for transformative advancements in the field of oncology.

Collaborations

Throughout his career, Rueher has collaborated closely with esteemed colleagues such as Georg Jaeschke and Antonio Ricci. Together, they have shared their knowledge and expertise to drive forward innovative projects aimed at revolutionizing cancer treatment strategies.

Conclusion

Daniel Rueher's relentless pursuit of innovation and his invaluable contributions to the field of pharmaceuticals have positioned him as a trailblazer in the development of novel cancer therapies. His work not only highlights his exceptional talent as an inventor but also underscores his commitment to improving patient outcomes and shaping the future of oncology research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…